These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11675331)

  • 1. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
    Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
    Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia.
    Morabito F; Mangiola M; Oliva B; Stelitano C; Callea V; Deaglio S; Iacopino P; Brugiatelli M; Malavasi F
    Leuk Res; 2001 Nov; 25(11):927-32. PubMed ID: 11597727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
    Ibrahim S; Keating M; Do KA; O'Brien S; Huh YO; Jilani I; Lerner S; Kantarjian HM; Albitar M
    Blood; 2001 Jul; 98(1):181-6. PubMed ID: 11418478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
    Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
    Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
    Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not.
    Ishibe N; Albitar M; Jilani IB; Goldin LR; Marti GE; Caporaso NE
    Blood; 2002 Aug; 100(3):1100-1. PubMed ID: 12150154
    [No Abstract]   [Full Text] [Related]  

  • 8. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
    Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U
    Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.
    Del Principe MI; Del Poeta G; Buccisano F; Maurillo L; Venditti A; Zucchetto A; Marini R; Niscola P; Consalvo MA; Mazzone C; Ottaviani L; Panetta P; Bruno A; Bomben R; Suppo G; Degan M; Gattei V; de Fabritiis P; Cantonetti M; Lo Coco F; Del Principe D; Amadori S
    Blood; 2006 Aug; 108(3):853-61. PubMed ID: 16601244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
    Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
    Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course.
    Chang CC; Cleveland RP
    Blood; 2002 Aug; 100(3):1106. PubMed ID: 12150158
    [No Abstract]   [Full Text] [Related]  

  • 12. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
    Hamblin TJ; Orchard JA; Ibbotson RE; Davis Z; Thomas PW; Stevenson FK; Oscier DG
    Blood; 2002 Feb; 99(3):1023-9. PubMed ID: 11807008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL): a comparison between antibody binding capacity (ABC) and relative median fluorescence (RMF).
    Dignum HM; Summerfield GP; Proctor SJ; Mainou-Fowler T
    Leuk Lymphoma; 2004 Jun; 45(6):1167-73. PubMed ID: 15359996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
    Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
    Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Dignum H; Taylor PR; Dickinson AM; Saunders PW; Proctor SJ; Summerfield GP
    Br J Haematol; 2002 Sep; 118(3):755-61. PubMed ID: 12181042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
    Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
    Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
    Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.
    Boonstra JG; von't Veer MB; Gratama JW
    J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognositc value of CD38 cell surface marker in chronic lymphocytic leukemia].
    Mhes L; Simon A; Rejtö L; Kiss A; Reményi G; Batár P; Telek B; Udvardy M
    Orv Hetil; 2003 Aug; 144(31):1531-5. PubMed ID: 14502867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.
    Zupo S; Massara R; Dono M; Rossi E; Malavasi F; Cosulich ME; Ferrarini M
    Blood; 2000 Feb; 95(4):1199-206. PubMed ID: 10666191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.